A counter insurgency study an analysis of local defenses

Local Defenses are view by many counterinsurgency strategists as an essential element in defeating an insurgency. Providing a population with a local defense organization will strongly support the government's strategy of extending its security and control over the rural areas affected by insurgent organizations. However every insurgency is unique and demands a unique counterinsurgency strategy to be defeated. There always will b e an important commonality: insurgent organizations need popular support to subsist. The final success of the government or the insurgents will be determined by the capacity of either both to win and retain the support among the rural population. The analysis of the four cases presented in this study clearly demonstrates each government's approach to the insurgent problem, including the use of local defenses to protect rural populations from insurgent attacks and influence. The organization of localdefenses during the Malayan Emergency, the El Salvador's Civil War, as well as the Vietnam War and the Terrorist Epoch in Peru proved to be a force multiplier for the government's effort, at least during the time period in which they were effectively implemented. The contribution of this analysis is not that of providing a framework or recipe for strategists to implement this kind of organizations. Rather, the contribution of this study is on a set of variables to be considered when planning the implementation of local defenses as part of a counterinsurgency effort.http://archive.org/details/acounterinsurgen109451424Lieutenant Commander, PeruMajor, United States ArmyApproved for public release; distribution is unlimited

Coronary heart disease risks associated with high levels of HDL cholesterol.

BackgroundThe association between high-density lipoprotein cholesterol (HDL-C) and coronary heart disease (CHD) events is not well described in individuals with very high levels of HDL-C (>80 mg/dL).Methods and resultsUsing pooled data from 6 community-based cohorts we examined CHD and total mortality risks across a broad range of HDL-C, including values in excess of 80 mg/dL. We used Cox proportional hazards models with penalized splines to assess multivariable, adjusted, sex-stratified associations of HDL-C with the hazard for CHD events and total mortality, using HDL-C 45 mg/dL and 55 mg/dL as the referent in men and women, respectively. Analyses included 11 515 men and 12 925 women yielding 307 245 person-years of follow-up. In men, the association between HDL-C and CHD events was inverse and linear across most HDL-C values; however at HDL-C values >90 mg/dL there was a plateau effect in the pattern of association. In women, the association between HDL-C and CHD events was inverse and linear across lower values of HDL-C, however at HDL-C values >75 mg/dL there were no further reductions in the hazard ratio point estimates for CHD. In unadjusted models there were increased total mortality risks in men with very high HDL-C, however mortality risks observed in participants with very high HDL-C were attenuated after adjustment for traditional risk factors.ConclusionsWe did not observe further reductions in CHD risk with HDL-C values higher than 90 mg/dL in men and 75 mg/dL in women

Development of an IgG4-RD Responder Index

IgG4-related disease (IgG4-RD) is a multiorgan inflammatory disease in which diverse organ manifestations are linked by common histopathological and immunohistochemical features. Prospective studies of IgG4-RD patients are required to clarify the natural history, long-term prognosis, and treatment approaches in this recently recognized condition. Patients with IgG4-RD have different organ manifestations and are followed by multiple specialties. Divergent approaches to the assessment of patients can complicate the interpretation of studies, emphasizing the critical need for validated outcome measures, particularly assessments of disease activity and response to treatment. We developed a prototype IgG4-RD Responder Index (IgG4-RD RI) based on the approach used in the development of the Birmingham Vasculitis Activity Score for Wegener's granulomatosis (BVAS/WG). The IgG4-RD RI was refined by members of the International IgG4-RD Symposium Organizing Committee in a paper case exercise. The revised instrument was applied retrospectively to fifteen IgG4-RD patients at our institution. Those scores were compared to physician's global assessment scale for the same visits. This paper describes the philosophy and goals of the IgG4-RD RI, the steps in the development of this instrument to date, and future plans for validation of this instrument as an outcome measure

The Use of an Optical Measurement System to Monitor Sports Performance

The purpose of this study was to compare ground contact time between an optical measurement system and a force platform. Participants in this study included six collegiate level athletes who performed drop jumps and sprint strike steps for a total of 15 repetitions each. Ground contact data was simultaneously collected from an optical measurement system and a force platform, at a sampling frequency of 1000 Hz. Data was then analyzed with Pearson’s correlation and paired sample t-tests. The measures from the optical measurement system were found to be significantly higher (p \u3c 0.001) than measures from the force platform in both conditions. Although significantly different, the extremely large relationships (0.979, 0.993) found between the two devices suggest the optical sensor is able to detect similar changes in performance to that of a force platform. Practitioners may continue to utilize optical sensors to monitor performance as it may provide a superior user-friendly alternative to more traditional based monitoring procedures, but must comprehend the inherent limitations due to the design of the optical sensors

Calibrating Type Ia Supernovae using the Planetary Nebula Luminosity Function I. Initial Results

We report the results of an [O III] lambda 5007 survey for planetary nebulae (PN) in five galaxies that were hosts of well-observed Type Ia supernovae: NGC 524, NGC 1316, NGC 1380, NGC 1448 and NGC 4526. The goals of this survey are to better quantify the zero-point of the maximum magnitude versus decline rate relation for supernovae Type Ia and to validate the insensitivity of Type Ia luminosity to parent stellar population using the host galaxy Hubble type as a surrogate. We detected a total of 45 planetary nebulae candidates in NGC 1316, 44 candidates in NGC 1380, and 94 candidates in NGC 4526. From these data, and the empirical planetary nebula luminosity function (PNLF), we derive distances of 17.9 +0.8/-0.9 Mpc, 16.1 +0.8/-1.1 Mpc, and 13.6 +1.3/-1.2 Mpc respectively. Our derived distance to NGC 4526 has a lower precision due to the likely presence of Virgo intracluster planetary nebulae in the foreground of this galaxy. In NGC 524 and NGC 1448 we detected no planetary nebulae candidates down to the limiting magnitudes of our observations. We present a formalism for setting realistic distance limits in these two cases, and derive robust lower limits of 20.9 Mpc and 15.8 Mpc, respectively. After combining these results with other distances from the PNLF, Cepheid, and Surface Brightness Fluctuations distance indicators, we calibrate the optical and near-infrared relations for supernovae Type Ia and we find that the Hubble constants derived from each of the three methods are broadly consistent, implying that the properties of supernovae Type Ia do not vary drastically as a function of stellar population. We determine a preliminary Hubble constant of H_0 = 77 +/- 3 (random) +/- 5 (systematic) km/s/Mpc for the PNLF, though more nearby galaxies with high-quality observations are clearly needed.Comment: 25 pages, 12 figures. Accepted for publication by the Astrophysical Journal. Figures degraded to comply with limit. Full paper is available at: http://www.as.ysu.edu/~jjfeldme/pnlf_Ia.pd

IgG4-Related Disease Is Not Associated with Antibody to the Phospholipase A2 Receptor

Patients with IgG4-related disease (IgG4-RD) share histopathological characteristics that are similar across affected organs. The finding of infiltration with IgG4+ plasma cells in the proper clinical and histopathological contexts connects a large number of clinical entities that were viewed previously as separate conditions. The renal involvement in IgG4-RD is usually characterized by tubulointerstitial nephritis, but membranous nephropathy has also been reported to be one of the renal complications of IgG4-RD. The recent discovery that a high proportion of patients with idiopathic membranous nephropathy (IMN) have IgG4 autoantibodies to the M-type phospholipase A2 receptor (PLA2R) in the circulation and glomerular immune deposits, together with the profound IgG4 hypergammaglobulinemia and occasional reports of membranous nephropathy in IgG4-RD, raised the question of a common antigen. To assess the presence of anti-PLA2R antibody in patients with IgG4-RD, we screened sera from 28 IgG4-RD patients by immunoblot. None of the patients in this cohort had detectable circulating anti-PLA2R antibodies. This study suggests that despite some clinical and serological overlaps between IgG4-RD and IMN,anti-PLA2R antibodies do not play a role in the pathogenesis of IgG4-RD. Additional studies of IgG4-RD with evidence of membranous nephropathy are important to exclude any definite relationship

Electrostatic Solar Sail: A Propellantless Propulsion Concept for an Interstellar Probe Mission

The propulsion of an electrostatic solar sail (E Sail) is obtained by extracting momentum from the solar wind through electrostatic repulsion of the positively charged solar wind ions (see Figure 1). The positively charged solar wind protons are deflected by the electric field created around the tethers.This electric field grows in diameter as the spacecraft moves away from the Sun, therefore the E Sail effective area grows. The growth of the E-Sail effective area allows the propulsive force to decrease as 1/r up to distances of 20 AU as it moves away from the Sun, unlike solar sail propulsion whose thrust decreases as 1/r 2 but only to distances of 5AU. This propulsive force is created without using propellant and, therefore, E-sail avoids both the mass and complexity of chemical rockets (that require large amounts of propellant, propellant storage tanks, plumbing, valves, and insulation)

Bisphosphonate's and Intermittent Parathyroid Hormone's Effect on Human Spinal Fusion: A Systematic Review of the Literature.

There has been a conscious effort to address osteoporosis in the aging population. As bisphosphonate and intermittent parathyroid hormone (PTH) therapy become more widely prescribed to treat osteoporosis, it is important to understand their effects on other physiologic processes, particularly the impact on spinal fusion. Despite early animal model studies and more recent clinical studies, the impact of these medications on spinal fusion is not fully understood. Previous animal studies suggest that bisphosphonate therapy resulted in inhibition of fusion mass with impeded maturity and an unknown effect on biomechanical strength. Prior animal studies demonstrate an improved fusion rate and fusion mass microstructure with the use of intermittent PTH. The purpose of this study was to determine if bisphosphonates and intermittent PTH treatment have impact on human spinal fusion. A systematic review of the literature published between 1980 and 2015 was conducted using major electronic databases. Studies reporting outcomes of human subjects undergoing 1, 2, or 3-level spinal fusion while receiving bisphosphonates and/or intermittent PTH treatment were included. The results of relevant human studies were analyzed for consensus on the effects of these medications in regards to spinal fusion. There were nine human studies evaluating the impact of these medications on spinal fusion. Improved fusion rates were noted in patients receiving bisphosphonates compared to control groups, and greater fusion rates in patients receiving PTH compared to control groups. Prior studies involving animal models found an improved fusion rate and fusion mass microstructure with the use of intermittent PTH. No significant complications were demonstrated in any study included in the analysis. Bisphosphonate use in humans may not be a deterrent to spinal fusion. Intermittent parathyroid use has shown early promise to increase fusion mass in both animal and human studies but further studies are needed to support routine use